Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

CDXS

+ Watchlist+ Portfolio

Codexis, Inc.

GridBrain

GridBrain Sign in

GridSentinel

GridSentinel Sign in

GridAegis

GridAegis Sign in

Key Metrics

Previous Close
$1.60
52-Week Range
$0.96 – $3.06
Market Cap
$173.02M
P/E (TTM)
EPS (TTM)
-0.33
Dividend Yield
Advanced Metrics
Price/Book
4.38
PEG Ratio
13.53
Return on Equity
-69.36%
Return on Assets
-11.74%
Gross Margin
24.27%
Operating Margin
-75.29%
Profit Margin
-39.55%
Current Ratio
3.06
Debt/Equity
2.20
Total Debt
$72.59M
Free Cash Flow
$2.13M
Revenue Growth
-2.70%
Earnings Growth
Enterprise Value
$190.69M

Market Snapshot

About

Codexis, Inc. is a protein engineering company that develops and commercializes custom enzymes for pharmaceutical, food, and industrial applications. Headquartered in Redwood City, California, Codexis utilizes its proprietary CodeEvolver protein engineering platform to create novel biocatalysts that enable more efficient, sustainable, and cost-effective manufacturing processes. The company's technology combines computational design, high-throughput screening, and directed evolution to optimize enzyme performance for specific customer applications. Codexis serves pharmaceutical companies by developing enzymatic processes for manufacturing active pharmaceutical ingredients (APIs) and intermediates, often replacing traditional chemical synthesis routes with greener alternatives. The company also applies its technology to food and nutrition applications, creating enzymes for improved manufacturing processes. Codexis operates through both product sales and collaborative research partnerships with major pharmaceutical and chemical companies. The company's platform addresses growing industry demand for sustainable manufacturing solutions and has demonstrated capabilities across diverse chemistry applications.